Therapeutic drug monitoring (TDM) has assumed an important place in patient
management in the last few decades. In this study, serum drug levels deter
mined in 7759 specimens sent to the Department of Pharmacology and Clinical
Pharmacology in 1994 and 1998 for TDM were retrospectively evaluated. Moni
tored drugs were carbamazepine, valproate, phenytoin, phenobarbital, digoxi
n, theophylline, and salicylate, The comparison of the results obtained for
the relevant 2 years showed that there was a remarkable increase in the nu
mber of requests for TDM per year and in the rate of serum drug levels that
were within therapeutic range. Serum antiepileptic drug level monitoring a
ccounted for a major part of the data. Overall data suggest that the use of
TDM in antiepileptic drugs is improving; conversely, digoxin and theophyll
ine are still not being properly monitored. In this study, the results are
discussed in the light of rational TDM criteria.